[144] Credit Acceptance Corp SEC Filing
Credit Acceptance Corp (CACC) submitted a Form 144 notice reporting a proposed sale of 6,000 common shares through Fidelity Brokerage Services on the NASDAQ with an aggregate market value of $3,012,000. The filing lists 11,237,661 shares outstanding for the class, so the proposed sale represents roughly 0.053% of that total. The securities are tied to an option granted on 12/30/2020 and show an acquisition/exercise date of 08/25/2025, with cash payment noted. The filer states there are no securities sold in the past three months and certifies no undisclosed material adverse information.
- Form 144 filed disclosing the planned sale of 6,000 common shares, which demonstrates regulatory compliance and transparency.
- Sale tied to an option exercise (option granted 12/30/2020), indicating the transfer arises from an established equity compensation event rather than an unexplained disposition.
- None.
Insights
TL;DR: Small insider sale notice tied to option exercise; unlikely to be materially market-moving given size relative to shares outstanding.
The Form 144 discloses a planned sale of 6,000 CACC shares valued at $3.01 million executed through a broker on NASDAQ and linked to an option originally granted in 2020. Relative to the reported 11.24 million shares outstanding for the class, the transaction is immaterial in share percentage terms (about 0.053%). No sales in the prior three months are reported, which reduces the likelihood this is part of a larger, ongoing disposition. The filing satisfies disclosure requirements under Rule 144 but provides no additional context on insider intent beyond the standard certification of no undisclosed material information.
TL;DR: The filing documents compliance with resale rules and ties the sale to option exercise; governance implications appear routine.
This notice indicates an insider or affiliated person is selling shares acquired via an option grant (12/30/2020) with exercise/acquisition noted as 08/25/2025 and cash payment. The signature statement affirms no undisclosed material information and mentions Rule 10b5-1 trading plans if applicable, but no plan date is provided. From a governance perspective, the filing is standard disclosure of a controlled sale; it does not allege any governance concern or unusual transfer structure based on the information supplied.